VASH1 and cervical squamous cell carcinoma: In addition, miR-221-3p enriched in cervical squamous cell carcinoma (CSCC)-derived EVs can be transferred to LECs, which promotes lymphangiogenesis and LNM by inhibiting the expression of vasohibin-1 (VASH1) (7).